ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

TAWN KEENEY MD

45 549 PLUMERIA STREET HAMAKUA HEALTH CENTER INC

Honokaa | Hawaii | 96727

(808) 775-7204

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 212

$425K Total Retail Price of All Prescriptions

Rank: 27 out of 212

404 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,767 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 500 416 1 2
HYDROCHLOROTHIAZIDE 430 398 2 8
OMEPRAZOLE 334 281 3 9
LOVASTATIN 334 272 3 12
METFORMIN HCL 301 243 5 5
ATORVASTATIN CALCIUM 243 172 6 6
LOSARTAN POTASSIUM 243 208 6 4
AMLODIPINE BESYLATE 203 177 8 3
HYDROCODONE-ACETAMINOPHEN 200 112 S3 9 10
FUROSEMIDE 190 172 10 11
LEVOTHYROXINE SODIUM 179 174 11 7
ALLOPURINOL 154 138 12 18
METOPROLOL TARTRATE 149 124 13 17
POTASSIUM CHLORIDE 144 128 14 27
SIMVASTATIN 136 115 15 1
DIGOXIN 122 97 16 41
ALENDRONATE SODIUM 117 113 17 16
METOPROLOL SUCCINATE 112 78 18 14
WARFARIN SODIUM 108 100 19 19
CARVEDILOL 101 71 20 23
PROAIR HFA 97 93 21 37
TAMSULOSIN HCL 94 88 22 21
ATENOLOL 88 75 23 13
DONEPEZIL HCL 88 88 23 25
ADVAIR DISKUS 86 82 25 33
RANITIDINE HCL 84 70 26 29
IBUPROFEN 81 31 27 62
OXYCODONE HCL 80 40 S2 28 39
PRAVASTATIN SODIUM 79 75 29 15
SPIRIVA 67 64 30 45
TERAZOSIN HCL 66 54 31 75
GLYBURIDE 66 50 R 31 53
DIOVAN 55 35 33 32
DILTIAZEM 24HR ER 55 50 33 97
BUPROPION HCL SR 54 22 35 195
PROPRANOLOL HCL 53 48 36 204
TRAZODONE HCL 50 15 37 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.